You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Clomipramine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for clomipramine hydrochloride and what is the scope of patent protection?

Clomipramine hydrochloride is the generic ingredient in two branded drugs marketed by Specgx Llc, Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Chemistry Hlth, Jubilant Cadista, Lupin Ltd, Mankind Pharma, Micro Labs, Mylan, Rk Pharma, Sandoz, Taro, Teva, Tulex Pharms Inc, Unique, Watson Labs, and Zydus Pharms, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clomipramine hydrochloride. Twenty-four suppliers are listed for this compound.

Summary for clomipramine hydrochloride
US Patents:0
Tradenames:2
Applicants:20
NDAs:22
Drug Master File Entries: 8
Finished Product Suppliers / Packagers: 24
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 23
What excipients (inactive ingredients) are in clomipramine hydrochloride?clomipramine hydrochloride excipients list
DailyMed Link:clomipramine hydrochloride at DailyMed
Recent Clinical Trials for clomipramine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Roma La SapienzaPhase 3
Fidia Farmaceutici s.p.a.Phase 4
Assiut UniversityPhase 3

See all clomipramine hydrochloride clinical trials

Pharmacology for clomipramine hydrochloride
Medical Subject Heading (MeSH) Categories for clomipramine hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for clomipramine hydrochloride

US Patents and Regulatory Information for clomipramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 216440-002 Mar 20, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 074364-001 Mar 29, 1996 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs CLOMIPRAMINE HYDROCHLORIDE clomipramine hydrochloride CAPSULE;ORAL 213219-003 Jun 22, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.